NovoCure Limited (NVCR) Gross Margin
- Gross margin · 12 months: Value 76.13%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 76.13% | Gross profit / revenue. Period ending 2026-06-30. $532.27M ÷ $699.19M × 100 ≈ 76.13% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 532.27M USD | Gross Profit |
| Revenue | 699.19M USD | |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $532.27M | $699.19M | (m) | 76.13% |
| 2026-03-31 | $507.13M | $674.41M | (m) | 75.20% |
| 2025-12-31 | $488.47M | $655.35M | (m) | 74.54% |
| 2025-09-30 | $484.08M | $642.27M | (m) | 75.37% |
| 2025-06-30 | $481.33M | $630.16M | (m) | 76.38% |
| 2025-03-31 | $479.70M | $621.71M | (m) | 77.16% |
| 2024-12-31 | $468.04M | $605.22M | (m) | 77.33% |
| 2024-09-30 | $441.47M | $577.74M | (m) | 76.41% |
| 2024-06-30 | $416.97M | $549.96M | (m) | 75.82% |
| 2024-03-31 | $393.30M | $525.66M | (m) | 74.82% |
| 2023-12-31 | $381.06M | $509.34M | (m) | 74.81% |
| 2023-09-30 | $379.37M | $503.98M | (m) | 75.27% |
| 2023-06-30 | $385.39M | $507.66M | (m) | 75.92% |
| 2023-03-31 | $405.72M | $522.48M | (m) | 77.65% |
| 2022-12-31 | $422.97M | $537.84M | (m) | 78.64% |
| 2022-09-30 | $426.96M | $542.62M | (m) | 78.68% |
| 2022-06-30 | $429.11M | $545.23M | (m) | 78.70% |
| 2022-03-31 | $421.66M | $537.88M | (m) | 78.39% |
| 2021-12-31 | $420.15M | $535.03M | (m) | 78.53% |
| 2021-09-30 | $432.44M | $545.77M | (m) | 79.24% |
| 2021-06-30 | $433.31M | $544.83M | (m) | 79.53% |
| 2021-03-31 | $418.84M | $527.23M | (m) | 79.44% |
| 2020-12-31 | $387.87M | $494.37M | (m) | 78.46% |
| 2020-09-30 | $346.50M | $449.65M | (m) | 77.06% |
| 2020-06-30 | $311.39M | $409.05M | (m) | 76.13% |
| 2020-03-31 | $286.55M | $379.84M | (m) | 75.44% |
| 2019-12-31 | $262.71M | $351.32M | (m) | 74.78% |
| 2019-09-30 | $234.91M | $321.76M | (m) | 73.01% |
| 2019-06-30 | $211.56M | $294.45M | (m) | 71.85% |
| 2019-03-31 | $187.63M | $269.25M | (m) | 69.69% |
| 2018-12-31 | $168.02M | $248.07M | (m) | 67.73% |
| 2018-09-30 | $159.40M | $232.06M | (m) | 68.69% |
| 2018-06-30 | $148.54M | $217.41M | (m) | 68.33% |
| 2018-03-31 | $132.09M | $194.27M | (m) | 67.99% |
| 2017-12-31 | $121.42M | $177.03M | (m) | 68.59% |
| 2017-09-30 | $102.67M | $153.61M | (m) | 66.84% |
| 2017-06-30 | $78.27M | $125.17M | (m) | 62.53% |
| 2017-03-31 | $54.75M | $104.72M | (m) | 52.29% |
| 2016-12-31 | $36.61M | $82.89M | (m) | 44.16% |
| 2016-09-30 | $23.42M | $65.03M | (m) | 36.01% |
| 2016-06-30 | $16.15M | $52.31M | (m) | 30.88% |
| 2016-03-31 | $16.24M | $40.93M | (m) | 39.67% |
| 2015-12-31 | $12.48M | $33.09M | (m) | 37.71% |
| 2015-09-30 | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | (m) | (m) |
| 2014-12-31 | $5.45M | $15.49M | (m) | 35.21% |
| 2014-09-30 | (m) | (m) | (m) | (m) |
| 2013-12-31 | $3.35M | $10.36M | (m) | 32.30% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |